(Q39520271)

12 September 2017

title

Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells (English)

1 reference

Human Induced Pluripotent Stem Cells

12 September 2017

main subject

1 reference

1 reference

1 reference

Shin-ichiro Ogawa

1

1 reference

12 September 2017

Yasuhito Tokumoto

series ordinal

2

1 reference

12 September 2017

Jun Miyake

series ordinal

3

1 reference

12 September 2017

Teruyuki Nagamune

series ordinal

4

1 reference

12 September 2017

language of work or name

1 reference

22 June 2011

1 reference

In Vitro Cellular & Developmental Biology - Animal

12 September 2017

published in

1 reference

12 September 2017

volume

47

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

464-469

1 reference

https://scigraph.springernature.com/pub.10.1007/s11626-011-9435-2

12 September 2017

exact match

0 references

cites work

Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Monoclonal antibody to a plasma membrane antigen of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Differentiation of human oligodendrocytes from pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Efficient induction of oligodendrocytes from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Variation in the safety of induced pluripotent stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

The oligodendrocyte and its many cellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

iPS cells produce viable mice through tetraploid complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-011-9435-2

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21695581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A fresh look at iPS cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21695581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11626-011-9435-2

1 reference

release_d2w2lhglhves5d5htzx2wm2joy

12 September 2017

Fatcat ID

0 references

1 reference